Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages
暂无分享,去创建一个
M. Graefen | H. Huland | N. Fossati | A. Briganti | S. Shariat | P. Karakiewicz | L. Cindolo | F. Preisser | P. Gild | Z. Tian | M. Marchioni | M. Bandini | R. Pompe | D. Tilki | Sami-Ramzi Leyh-Bannurah